A few days ago Abdur Rub, Head of the In Vitro Diagnostics Program at the Agency for Science, Technology and Research (A*STAR) in Singapore commented on a previous FluidicMEMS post on circulating tumor cells (CTCs). He maintains a terrific compilation of commercial CTC efforts worldwide (shown above). There’s a lot of commercial activity in the CTC space, and I suspect there may be even more companies out there—for example Rarecyte. Abdur keeps the list updated, so this is a great site to check back with every so often if you’re following the CTC world. Not only does he maintain this list, he also blogs. Check it out here!
a blog about microfluidics and bioMEMS technologies and how they can help solve real-world problems. Written by Lily Kim, a biomedical-engineer-turned-technology-strategist, FluidicMEMS covers new developments fresh from academia as well as the process of bringing these technologies into the world.
Tag Cloudacademia art biomems biomimetic biotech blogging cancer challenges commercialization diagnostic DIY diybio droplets education ethics event food FridayFlick funding globalhealth healthcare Innovation interview jobs killerapp lab-on-a-chip manufacturing marketing medicine meta microbioreactors microfluidics nanotechnology neuroscience news paper pharma point of care policy risk sequencing stemcells venturecapital web2.0 webinar
- No public Twitter messages.